5.175USD+1.47%Mkt Cap: 41.38M $P/E: —2d ago
PAVmed Inc. engages in acquiring, developing, and commercializing novel products that target unmet needs in the United States. The company's lead products include CarpX, a patented, single-use, disposable, and minimally …
Industry Peers
Medical DevicesKey Statistics
Company
Market Cap41.38M $
Enterprise Value37.33M $
Revenue (TTM)112.00K $
Gross Profit-147.00K $
Net Income (TTM)401.00K $
Revenue/Share0.0470 USD
Last Price5.175 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees41
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-2.11
PEG—
EV/EBITDA-1.40
EV/Revenue333.29
P/S369.81
P/B0.91
EPS (TTM)-17.21
EPS (Forward)-2.45
52W Range
3.8805% of range28.44
52W High28.44 USD
52W Low3.880 USD
Profitability
Gross Margin-207.04%
Oper. Margin-21278.79%
EBITDA Margin0.00%
Profit Margin564.79%
ROE1.18%
ROA1.03%
Growth
Revenue Growth450.00%
Earnings Growth—
Cash Flow & Leverage
Operating CF-5.21M $
CapEx (TTM)31.00K $
FCF Margin-10652.01%
FCF Yield-28.83%
Net Debt13.00M $
Net Debt/EBITDA-0.49
Balance Sheet
Debt/Equity0.39
Current Ratio1.19
Quick Ratio1.00
Book Value/Sh5.705 USD
Cash/Share0.5820 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:30
Split DateJan 2, 2026
Analyst Consensus
Rating1.5 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)36.00 USD
Upside (mean)+595.7%
Target Range16.00 USD – 56.00 USD
$16.00+595.7% to mean$56.00
# Analysts2
Ownership
Shares Out.8.00M
Float4.17M
Insiders39.52%
Institutions26.26%
Short Interest
Short Ratio1.4d
Short % Float0.39%
Short % Out.0.29%
Shares Short20.42K
Short (prev mo.)33.65K
Technical
SMA 505.173 (+0.0%)
SMA 2008.063 (-35.8%)
Beta0.52
S&P 52W Chg18.16%
Avg Vol (30d)27.99K
Avg Vol (10d)86.60K
Technical Indicators
RSI (14)51.0
MACD-0.0905
MACD Signal-0.1469
MACD Hist.+0.0563
BB Upper5.589 USD
BB Middle4.972 USD
BB Lower4.354 USD
BB Width24.85%
ATR (14)0.5010 USD
Vol Ratio (20d)0.17x